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Volume 57, Number 5S Abstracts 95SEarly results: 30-day mortality was 3.3%. Limb loss rate
was signiﬁcantly lower in the upper (n ¼ 2; 2.9%) than the
lower limb (n ¼ 12; 13.3%; P < .05). Primary patency was
93% (upper limb) and 89% (lower limb): early graft occlu-
sions occurred both in the upper (n ¼ 5; 7%) and the lower
limb (n ¼ 10; 11%; P ¼ .59). Occlusions were followed by
amputation in 8 cases (upper limb, 1 of 5; lower limb, 7 of
10) despite successful revision of the occluded grafts.
Long-term results after a median follow-up period of 6.0
years (range, 0.3-23.4): upper limb (68% of patients were
followed): no late limb loss, no vascular reintervention,
patency: 97%; lower limb (66% of patients were followed):
one late limb loss, one redo bypass for vein graft dilation,
patency: 98%.
Conclusions: Repair of arterial injuries in the limbs
using vein grafts is hampered by a considerable risk of early
occlusion, probably caused by insufﬁcient anticoagulation
and due to associated injuries. Early graft occlusion is
frequently followed by limb loss, especially in the lower
limb. However, during long-term follow-up, occlusions
of interposed vein grafts, and vascular reinterventions as
well as late amputations are uncommon.
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Objectives: This study examined variation and impact
of antiplatelet (AP) and statin therapy on early and late mor-
tality in patients undergoing vascular surgery in our region.
Methods: We studied all patients (n ¼ 14,490) under-
going primary elective CEA/CAS (n ¼ 7503), supra/
infrainguinal bypass (n ¼ 3816), and open/endo AAA
repair with known coronary risk factors (n ¼ 3171) from
2005-2012 in the Vascular Study Group of New England.
We deﬁned “optimal medical management” as treatment
with both AP and statin agents, preoperatively and at
discharge. We used multivariable analysis to determine
the independent impact of AP and statin therapy on 30-
day mortality and 5-year survival, and analyzed center vari-
ation in medication use.
Results: Preoperative AP and statin use was associated
with reduced 30-day mortality (0.97 vs 1.58%, RR 0.61; P
< .01). AP and statin prescription at discharge was additive
in survival beneﬁt (Fig). Preoperative and discharge AP and
statin was associated with improved 5-year survival (HR,
0.68; CI, 0.62-0.77; P < .01) and consistent across
procedure types. The use of optimal medical management
increased during the study interval (55% in 2005 to 68% in
2012; P < .01). However, the proportion of patients on
optimal medical therapy varied signiﬁcantly among the 29
centers, from 40 to 86%; P < .01.Conclusions: Optimal medical management was asso-
ciated with reduced short and long term mortality.
However, one-third of patients are sub-optimally managed
in real world practice. This is an opportunity for quality
improvement that can substantially improve survival after
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Objectives: Under the Affordable Care Act, patient
satisfaction and the quality of care delivered as measured
by the Hospital Consumer Assessment of Healthcare
Providers and Systems (HCAHPS) will assume an increas-
ingly important role. While HCAHPS is a standardized
patient satisfaction survey, there is minimal published
data describing factors associated with high scores. This
study evaluates factors associated with HCAHPS satisfac-
tion in vascular surgery patients.
Methods: This study is a retrospective review of
vascular surgery HCAHPS surveys at a single academic
center from 2011-2012. Global satisfaction, evaluated by
hospital satisfaction and willingness to recommend the
hospital, was the primary endpoint. Other survey domains,
demographics and clinical variables including complica-
tions, procedure and ICU stay were also evaluated. Only
top answers were considered positive (“always”; 10/10
satisfaction; deﬁnite recommendation).
